Posted by: admin on: June 27, 2011
The US Food and Drug Administration (FDA) approved an oral contraceptive — the first of its kind — that is intended both to prevent pregnancy and reduce the risk for neural tube defects in newborns if and when users of the pill give birth. The new contraceptive contains levomefolate calcium, a metabolite of folic […]
Posted by: admin on: June 18, 2011
The control of hypertension with perindopril amlodipine combination far supersedes, the so far considered effective combination of atenenol and diuretic. Here is the new study. Team@CMHF
Posted by: admin on: May 27, 2011
February 14, 2011 – According to online results of an observational study reported in the Archives of Internal Medicine, “Concurrent use of proton pump inhibitors (PPIs) is associated with a dose-dependent loss of protection against hip fracture with alendronate in elderly patients.”
Posted by: admin on: May 10, 2011
Resistance to Ciprofloxacin following misuse in the aftermath of Dombivali fever, in ‘80s may be remembered by all. Of late allergic reactions to quinolones have been noticed with increasing frequency. The reactions are not immediate type hypersensitivity but cross reactivity. Team@CMHF
Posted by: admin on: May 6, 2011
All drugs are monitored rigidly, even after having been approved by FDA, for reported adverse effects and drug interactions. It is duty of every practitioner to report – both to the manufacturer and FDA – any unreported adverse effect (maybe in one patient) for rational monitoring and necessary action. Team@CMHF